Clinical monitoring of patients with age-related macular degeneration treated with intravitreal bevacizumab or ranibizumab. [electronic resource]
Producer: 20150212Description: 285-91 p. digitalISSN:- 2325-8179
- Aged
- Aged, 80 and over
- Analysis of Variance
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Bevacizumab
- Drug Administration Schedule
- Female
- Humans
- Intravitreal Injections
- Macular Degeneration -- drug therapy
- Male
- Ranibizumab
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.